Daniel Apel plan to sell securities of Arrowhead Pharmaceuticals Inc. under Form 144

Daniel Apel filed Form 144 to notify SEC of plan to sell 13095 units of Arrowhead Pharmaceuticals Inc. securities around 2026-04-22, with aggregate market value of $934,206.16. The total outstanding units is 140032190.0. The amount planned to be sold represents 0.01% of total outstanding units;